Skip to main content
. 2018 Aug 28;2018:4369253. doi: 10.1155/2018/4369253

Figure 2.

Figure 2

Overall survival curves of patients for intrahepatic cholangiocarcinoma with different SHMT2 expression levels. Patients with low expression of SHMT2 have a significantly better survival rate than those with high SHMT2 expression (P = 0.030).